Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

Journal:
Journal of Clinical Oncology
Published:
DOI:
10.1200/jco-25-00742
Affiliations:
15
Authors:
24
Go to article
Institutions Authors Share
Institute Gustave-Roussy (IGR), France
6.833333
 0.28
Spotlight Medical, France
4.000000
 0.17
UNICANCER Group, France
3.000000
 0.13
Curie Institute, France
2.333333
 0.10
Molecular Predictors and New Targets in Oncology, France
1.333333
 0.06
City of Hope Comprehensive Cancer Center, United States of America (USA)
1.000000
 0.04
The University of Texas MD Anderson Cancer Center, United States of America (USA)
1.000000
 0.04
Centre Léon Bérard (CLB), France
1.000000
 0.04
National PRecISion Medicine Center in Oncology (IHU Prism), France
0.833333
 0.03
Paris-Cardiovascular Research Center (PARCC), France
0.500000
 0.02
Imagerie Moléculaire et Stratégies Théranostiques (IMoST), France
0.500000
 0.02
Centre Jean Perrin (CJP), France
0.500000
 0.02
Centre for Research in Epidemiology and Population Health (CESP), France
0.500000
 0.02
Computational Oncology, France
0.333333
 0.01
Mines ParisTech - PSL, France
0.333333
 0.01
Interested in Oncology and Carcinogenesis?